The Nucleic Acid Isolation and Purification Market is projected to be valued at USD 1,178.6 million in 2025 and is expected to grow at a CAGR of 5.6% from 2025 to 2035, reaching USD 2,038.1 million by ...

Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable ...

As viral vaccines are increasingly used to meet global health needs, the pharmaceutical industry is manufacturing larger ...

Purdue University-connected startup Molecular Intelligence supports research scientists in bioengineering, medical science ...

In the pursuit of understanding the pathogenic expression mechanisms of bacteria and the advancements in biofoundry ...

Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic diseases marked by too low levels of specific cellular proteins.

Maravai LifeSciences Holdings, Inc.’s MRVI share price has surged by 10.86%, which has investors questioning if this is right ...

Stress granules (SGs) are transient organelles that form when cells experience stress, serving as critical hubs for RNA metabolism and cellular survival.

Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform ...

Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics ... gene therapy, and RNA therapeutic development with cutting-edge ...

Genevant Sciences is a leading nucleic acid delivery company with world-class platforms ... and is the delivery technology ...

Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic ...